|
LAZARD LTD
|
|
COMPENSATION AND BENEFITS - ANALYSIS
|
|
(unaudited)
|
|
($ in millions except share price)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
2007
|
|
2008
|
|
2009
|
|
2010
|
|
2011
|
|
2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ADJUSTED U.S. GAAP BASIS (c)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Base salary and benefits
|
|
$397.8
|
|
$456.2
|
|
$467.7
|
|
$422.6
|
|
$452.9
|
|
$506.4
|
|
$515.8
|
|
Cash incentive compensation
|
|
470.6
|
|
562.1
|
|
224.7
|
|
404.6
|
|
472.8
|
|
372.4
|
|
367.2
|
|
Total cash compensation and benefits
|
|
868.4
|
|
1,018.3
|
|
692.4
|
|
827.2
|
|
925.7
|
|
878.8
|
|
883.0
|
|
Amortization of deferred incentive awards
|
|
23.0
|
|
104.8
|
|
238.3
|
|
333.4
|
|
240.5
|
|
289.4
|
|
334.8
|
|
Compensation and benefits - Adjusted U.S. GAAP basis (i)
|
$891.4
|
|
$1,123.1
|
|
$930.7
|
|
$1,160.6
|
|
$1,166.2
|
|
$1,168.2
|
|
$1,217.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
% of Operating Revenue
|
|
56.7%
|
|
55.7%
|
|
55.6%
|
|
71.7%
|
|
58.9%
|
|
62.0%
|
|
61.8%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AWARDED BASIS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total cash compensation and benefits (per above)
|
$868.4
|
|
$1,018.3
|
|
$692.4
|
|
$827.2
|
|
$925.7
|
|
$878.8
|
|
$883.0
|
|
Deferred year-end incentive awards
|
|
203.9
|
|
336.7
|
|
351.7
|
|
239.3
|
|
292.7
|
|
282.4
|
|
272.4
|
|
Compensation and benefits - before special deferred
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
incentive awards
|
|
1,072.3
|
|
1,355.0
|
|
1,044.1
|
|
1,066.5
|
|
1,218.4
|
|
1,161.2
|
|
1,155.4
|
|
Sign-on and other special deferred incentive awards (j)
|
12.8
|
|
87.9
|
|
179.6
|
|
39.2
|
|
27.3
|
|
40.0
|
|
42.1
|
|
Year-end foreign exchange adjustment (k)
|
|
6.9
|
|
6.6
|
|
(9.7)
|
|
5.6
|
|
3.3
|
|
(4.6)
|
|
1.4
|
|
Total Compensation and benefits - Notional
|
|
1,092.0
|
|
1,449.5
|
|
1,214.0
|
|
1,111.3
|
|
1,249.0
|
|
1,196.6
|
|
1,198.9
|
|
Adjustment for actual/estimated forfeitures (l)
|
|
(23.8)
|
|
(35.2)
|
|
(21.7)
|
|
(17.1)
|
|
(27.8)
|
|
(28.0)
|
|
(27.4)
|
|
Total Compensation and benefits - Awarded
|
|
$1,068.2
|
|
$1,414.3
|
|
$1,192.3
|
|
$1,094.2
|
|
$1,221.2
|
|
$1,168.6
|
|
$1,171.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
% of Operating Revenue - Awarded Basis
|
|
68.0%
|
|
70.2%
|
|
71.2%
|
|
67.6%
|
|
61.7%
|
|
62.0%
|
|
59.4%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Memo:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total value of deferred equity-based year end
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
incentive awards
|
|
$198.9
|
|
$332.2
|
|
$202.3
|
|
$233.8
|
|
$261.4
|
|
$192.7
|
|
TBD
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity-based year end awards - share equivalents ('000)
|
3,971
|
|
8,787
|
|
6,489
|
|
6,477
|
|
5,775
|
|
6,932
|
|
TBD
|
|
|
Price at issuance
|
|
$50.08
|
|
$37.81
|
|
$31.17
|
|
$36.10
|
|
$45.26
|
|
$27.80
|
|
TBD
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred compensation awards ratio (m)
|
|
19.1%
|
|
23.8%
|
|
29.5%
|
|
21.9%
|
|
24.0%
|
|
24.2%
|
|
23.3%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating revenue
|
|
$1,571.1
|
|
$2,014.8
|
|
$1,675.1
|
|
$1,617.6
|
|
$1,978.5
|
|
$1,883.9
|
|
$1,970.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
This presentation includes non-U.S. GAAP ("non-GAAP") measures. Our
non-GAAP measures are not meant to be considered in isolation or as
a substitute for comparable U.S. GAAP measures, and should be read
only in conjunction with our consolidated financial statements
prepared in accordance with U.S. GAAP. For a detailed explanation of
the adjustments made to comparable U.S. GAAP measures, see
Reconciliation of U.S. GAAP to Adjusted Statement of Operations and
Notes to Financial Schedules.
|
|
LAZARD LTD
|
|
UNAUDITED CONDENSED CONSOLIDATED
|
|
STATEMENT OF FINANCIAL CONDITION
|
|
(U.S. GAAP)
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
December 31,
|
|
($ in thousands)
|
|
|
2012
|
|
2011
|
|
|
|
|
|
|
|
|
ASSETS
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
|
$850,190
|
|
$1,003,791
|
|
Deposits with banks
|
|
|
292,494
|
|
286,037
|
|
Cash deposited with clearing organizations and other segregated cash
|
65,232
|
|
75,506
|
|
Receivables
|
|
|
478,043
|
|
504,455
|
|
Investments
|
|
|
414,673
|
|
378,521
|
|
Goodwill and other intangible assets
|
|
392,822
|
|
393,099
|
|
Other assets
|
|
|
493,439
|
|
440,527
|
|
|
|
|
|
|
|
|
Total Assets
|
|
|
$2,986,893
|
|
$3,081,936
|
|
|
|
|
|
|
|
|
LIABILITIES & STOCKHOLDERS' EQUITY
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
Deposits and other customer payables
|
|
$269,763
|
|
$288,427
|
|
Accrued compensation and benefits
|
|
467,578
|
|
383,513
|
|
Senior debt
|
|
|
1,076,850
|
|
1,076,850
|
|
Other liabilities
|
|
|
521,162
|
|
466,290
|
|
Total liabilities
|
|
2,335,353
|
|
2,215,080
|
|
|
|
|
|
|
|
|
Commitments and contingencies
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' equity
|
|
|
|
|
|
|
Preferred stock, par value $.01 per share
|
|
-
|
|
-
|
|
Common stock, par value $.01 per share
|
|
1,282
|
|
1,230
|
|
Additional paid-in capital
|
|
|
846,050
|
|
659,013
|
|
Retained earnings
|
|
|
182,647
|
|
258,646
|
|
Accumulated other comprehensive loss, net of tax
|
(110,541)
|
|
(88,364)
|
|
|
|
|
919,438
|
|
830,525
|
|
Class A common stock held by subsidiaries, at cost
|
(349,782)
|
|
(104,382)
|
|
Total Lazard Ltd stockholders' equity
|
569,656
|
|
726,143
|
|
Noncontrolling interests
|
|
|
81,884
|
|
140,713
|
|
Total stockholders' equity
|
|
|
651,540
|
|
866,856
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders' equity
|
|
$2,986,893
|
|
$3,081,936
|
|
LAZARD LTD
|
|
|
RECONCILIATION OF U.S. GAAP TO SELECTED SUMMARY FINANCIAL
INFORMATION (a)
|
|
|
(unaudited)
|
|
|
|
Three Months Ended
|
|
Year Ended
|
|
|
|
December 31,
|
|
September 30,
|
|
December 31,
|
December 31,
|
|
December 31,
|
|
|
($ in thousands, except per share data)
|
2012
|
|
2012
|
|
2011
|
|
2012
|
|
2011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Revenue
|
|
|
Net revenue - U.S. GAAP Basis
|
$560,693
|
|
$428,806
|
|
$451,778
|
|
$1,912,448
|
|
$1,829,512
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
Gain on repurchase of subordinated debt
|
-
|
|
-
|
|
-
|
|
-
|
|
(18,171)
|
|
|
Revenue related to noncontrolling interests (n)
|
(3,963)
|
|
(1,193)
|
|
(2,351)
|
|
(14,104)
|
|
(16,696)
|
|
|
Loss (gain) related to Lazard Fund Interests ("LFI") and other
similar arrangements
|
(2,918)
|
|
(4,728)
|
|
(937)
|
|
(7,557)
|
|
3,024
|
|
|
Interest expense
|
19,835
|
|
20,326
|
|
20,217
|
|
80,029
|
|
86,200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating revenue, as adjusted
|
$573,647
|
|
$443,211
|
|
$468,707
|
|
$1,970,816
|
|
$1,883,869
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Compensation & Benefits Expense
|
|
|
Compensation & benefits expense - U.S. GAAP Basis
|
$445,602
|
|
$283,818
|
|
$338,934
|
|
$1,351,129
|
|
$1,168,945
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
Charges pertaining to cost savings initiatives (Q4)
|
(99,987)
|
|
-
|
|
-
|
|
(99,987)
|
|
-
|
|
|
Charges pertaining to staff reductions (Q1)
|
-
|
|
-
|
|
-
|
|
(21,754)
|
|
-
|
|
|
(Charges) credits pertaining to LFI and other similar arrangements
compensation liability
|
(2,918)
|
|
(4,728)
|
|
(937)
|
|
(7,557)
|
|
3,024
|
|
|
Compensation related to noncontrolling interests (n)
|
(931)
|
|
(1,020)
|
|
(990)
|
|
(4,040)
|
|
(3,740)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Compensation & benefits expense, as adjusted
|
$341,766
|
|
$278,070
|
|
$337,007
|
|
$1,217,791
|
|
$1,168,229
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-Compensation Expense
|
|
|
Non-compensation expense - Subtotal - U.S. GAAP Basis
|
$120,288
|
|
$98,262
|
|
$127,302
|
|
$437,434
|
|
$424,639
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
Charges pertaining to cost savings initiatives (Q4)
|
(2,589)
|
|
-
|
|
-
|
|
(2,589)
|
|
-
|
|
|
Charges pertaining to staff reductions (Q1)
|
-
|
|
-
|
|
-
|
|
(2,905)
|
|
-
|
|
|
Write-off of Lazard Alternative Investment Holdings option prepayment
|
-
|
|
-
|
|
(5,500)
|
|
-
|
|
(5,500)
|
|
|
Provision for onerous lease contract for UK facility
|
-
|
|
-
|
|
(5,539)
|
|
-
|
|
(5,539)
|
|
|
Amortization of intangible assets related to acquisitions
|
(2,187)
|
|
(2,494)
|
|
(7,019)
|
|
(8,359)
|
|
(11,915)
|
|
|
Non-compensation expense related to noncontrolling interests (n)
|
(604)
|
|
(655)
|
|
(570)
|
|
(2,558)
|
|
(2,008)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-compensation expense, as adjusted
|
$114,908
|
|
$95,113
|
|
$108,674
|
|
$421,023
|
|
$399,677
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings From Operations
|
|
|
Operating Income (loss) - U.S. GAAP Basis
|
($5,197)
|
|
$46,726
|
|
($14,887)
|
|
$123,885
|
|
$235,499
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
Charges pertaining to cost savings initiatives (Q4)
|
102,576
|
|
-
|
|
-
|
|
102,576
|
|
-
|
|
|
Charges pertaining to staff reductions (Q1)
|
-
|
|
-
|
|
-
|
|
24,659
|
|
-
|
|
|
Gain on repurchase of subordinated debt
|
-
|
|
-
|
|
-
|
|
-
|
|
(18,171)
|
|
|
Write-off of Lazard Alternative Investment Holdings option prepayment
|
-
|
|
-
|
|
5,500
|
|
-
|
|
5,500
|
|
|
Provision for onerous lease contract for UK facility
|
-
|
|
-
|
|
5,539
|
|
-
|
|
5,539
|
|
|
Revenue related to noncontrolling interests (n)
|
(3,963)
|
|
(1,193)
|
|
(2,351)
|
|
(14,104)
|
|
(16,696)
|
|
|
Interest expense
|
19,835
|
|
20,326
|
|
20,217
|
|
80,029
|
|
86,200
|
|
|
Expenses related to noncontrolling interests (n)
|
1,535
|
|
1,675
|
|
1,560
|
|
6,598
|
|
5,748
|
|
|
Amortization of intangible assets related to acquisitions
|
2,187
|
|
2,494
|
|
7,019
|
|
8,359
|
|
11,915
|
|
|
Adjustment related to the provision pursuant to the tax receivable
agreement ("TRA")
|
-
|
|
-
|
|
429
|
|
-
|
|
429
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings from operations, as adjusted
|
$116,973
|
|
$70,028
|
|
$23,026
|
|
$332,002
|
|
$315,963
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income attributable to Lazard Ltd
|
|
|
Net income (loss) attributable to Lazard Ltd - U.S. GAAP Basis
|
($5,365)
|
|
$33,301
|
|
($4,793)
|
|
$84,309
|
|
$174,917
|
|
|
Adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
Charges pertaining to cost savings initiatives (Q4)
|
102,576
|
|
-
|
|
-
|
|
102,576
|
|
-
|
|
|
Charges pertaining to staff reductions (Q1)
|
-
|
|
-
|
|
-
|
|
24,659
|
|
-
|
|
|
Gain on repurchase of subordinated debt
|
-
|
|
-
|
|
-
|
|
-
|
|
(18,171)
|
|
|
Write-off of Lazard Alternative Investment Holdings option prepayment
|
-
|
|
-
|
|
5,500
|
|
-
|
|
5,500
|
|
|
Provision for onerous lease contract for UK facility
|
-
|
|
-
|
|
5,539
|
|
-
|
|
5,539
|
|
|
Tax (benefits) allocated to adjustments
|
(15,542)
|
|
140
|
|
(4,634)
|
|
(21,108)
|
|
-
|
|
|
Amount attributable to LAZ-MD Holdings
|
(1,340)
|
|
(49)
|
|
(390)
|
|
(2,449)
|
|
411
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustment for full exchange of exchangeable interests (o):
|
|
|
|
|
|
|
|
|
|
|
|
Tax adjustment for full exchange
|
(200)
|
|
5
|
|
(190)
|
|
(643)
|
|
(1,135)
|
|
|
Amount attributable to LAZ-MD Holdings
|
1,498
|
|
1,987
|
|
399
|
|
7,563
|
|
11,553
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income, as adjusted
|
$81,627
|
|
$35,384
|
|
$1,431
|
|
$194,907
|
|
$178,614
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted net income (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
U.S. GAAP Basis
|
($0.05)
|
|
$0.26
|
|
($0.04)
|
|
$0.65
|
|
$1.36
|
|
|
Non-GAAP Basis, as adjusted
|
$0.61
|
|
$0.26
|
|
$0.01
|
|
$1.44
|
|
$1.31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
This presentation includes non-U.S. GAAP ("non-GAAP") measures. Our
non-GAAP measures are not meant to be considered in isolation or as
a substitute for comparable U.S. GAAP measures, and should be read
only in conjunction with our consolidated financial statements
prepared in accordance with U.S. GAAP. For a detailed explanation of
the adjustments made to comparable U.S. GAAP measures, see Notes to
Financial Schedules.
|
|
|
LAZARD LTD
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notes to Financial Schedules
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a)
|
Selected Summary Financial Information are non-U.S. GAAP
("non-GAAP") measures. Lazard believes that presenting results and
measures on an adjusted basis in conjunction with U.S. GAAP measures
provides the most meaningful basis for comparison of its operating
results across periods. (See Reconciliation of U.S. GAAP to Selected
Summary Financial Information)
|
|
|
|
|
|
|
(b)
|
A non-GAAP measure which excludes (i) gains/losses related to the
changes in the fair value of investments held in connection with
Lazard Fund Interests and other similar deferred compensation
arrangements for which a corresponding equal amount is excluded from
compensation & benefits expense, (ii) revenues related to
non-controlling interests (see (n) below), (iii) interest expense
primarily related to corporate financing activities, and (iv) for
the twelve month period ended December 31, 2011, excludes the gain
on repurchase of the Company's subordinated debt. (See
Reconciliation of U.S. GAAP to Selected Summary Financial
Information)
|
|
|
|
|
|
|
(c)
|
A non-GAAP measure which excludes (i) charges/credits related to the
changes in the fair value of the compensation liability recorded in
connection with Lazard Fund Interests and other similar deferred
compensation arrangements, (ii) compensation and benefits related to
noncontrolling interests (see (n) below), (iii) for the three and
twelve month periods ended December 31, 2012, charges pertaining to
the implementation of cost-savings initiatives (see (g) below), and
(iv) for the twelve month period ended December 31, 2012, certain
first quarter charges pertaining to staff reductions (see (g)
below). (See Reconciliation of U.S. GAAP to Selected Summary
Financial Information)
|
|
|
|
|
|
|
(d)
|
A non-GAAP measure which excludes (i) amortization of intangible
assets related to acquisitions, (ii) expenses related to
noncontrolling interests (see (n) below), (iii) for the three and
twelve month periods ended December 31, 2012, charges pertaining to
the implementation of cost-savings initiatives (see (g) below), and
(iv) for the twelve month period ended December 31, 2012, certain
first quarter charges pertaining to staff reductions (see (g)
below). The three and twelve month periods for 2011 are also
adjusted to exclude a provision for an onerous lease contract for
the Company's leased facility in the U.K. and a charge related to
the write-off of a partial prepayment of the Company's option to
acquire the fund management activities of Lazard Alternative
Investment Holdings. (See Reconciliation of U.S. GAAP to Selected
Summary Financial Information)
|
|
|
|
|
|
|
(e)
|
A non-GAAP measure which excludes (i) amortization of intangible
assets related to acquisitions, (ii) interest expense primarily
related to corporate financing activities, (iii) revenues and
expenses related to noncontrolling interests (see (n) below), (iv)
for the three and twelve month periods ended December 31, 2012,
charges pertaining to the implementation of cost-savings initiatives
(see (g) below), (v) for the twelve month period ended December 31,
2012, certain first quarter charges pertaining to staff reductions
(see (g) below), (vi) for the twelve month period ended December 31,
2011, gain on repurchase of the Company's subordinated debt, (vii)
for the three and twelve month periods for 2011 a provision for an
onerous lease contract for the Company's leased facility in the U.K.
and a charge related to the write-off of a partial prepayment of the
Company's option to acquire the fund management activities of Lazard
Alternative Investment Holdings, and (viii) for the three and twelve
month periods ended December 31, 2011, a provision pursuant to the
tax receivable agreement of $429. (See Reconciliation of U.S. GAAP
to Selected Summary Financial Information)
|
|
|
|
|
|
|
(f)
|
Represents earnings from operations as a percentage of operating
revenue, and is a non-GAAP measure. (See Reconciliation of U.S. GAAP
to Selected Summary Financial Information)
|
|
|
|
|
|
|
(g)
|
A non-GAAP measure which is adjusted to reflect the full conversion
of outstanding exchangeable interests held by members of LAZ-MD
Holdings and excludes (i) for the three and twelve month periods
ended December 31, 2012, charges pertaining to cost-savings
initiatives including severance benefit payments, acceleration of
unrecognized amortization of deferred incentive compensation
previously granted to individuals terminated and other
non-compensation related costs, net of applicable tax benefits, (ii)
for the twelve month period ended December 31, 2012, certain first
quarter charges pertaining to staff reductions including severance,
benefit payments and acceleration of unrecognized amortization of
deferred incentive compensation previously granted to individuals
terminated, net of applicable tax benefits, (iii) for the twelve
month period ended December 31, 2011, excludes gain on repurchase of
the Company's subordinated debt, net of applicable tax, (iv) for the
three and twelve month periods ended December 31, 2011, a provision
for an onerous lease contract for the Company's leased facility in
the U.K. and a charge related to the write-off of a partial
prepayment of the Company's option to acquire the fund management
activities of Lazard Alternative Investment Holdings. (See
Reconciliation of U.S. GAAP to Selected Summary Financial
Information)
|
|
|
|
|
|
|
(h)
|
Effective tax rate is a non-GAAP measure which is computed based on
a quotient, the numerator of which is the provision (benefit) for
income taxes of $14,572, $12,908 and ($1,511) for the three month
periods ended December 31, 2012, September 30, 2012 and December 31,
2011, respectively, and $52,772 and $46,504 for the twelve month
periods ended December 31, 2012 and 2011, respectively, and the
denominator of which is pre-tax income (loss) of $97,300, $46,726
and ($3,419) for the three month periods ended December 31, 2012,
September 30, 2012 and December 31, 2011, respectively, and $251,041
and $228,796 for the twelve month periods ended December 31, 2012
and 2011, respectively, exclusive of net income (loss) attributable
to noncontrolling interests of $1,101, ($1,566) and ($3,339) for the
three month periods ended December 31, 2012, September 30, 2012 and
December 31, 2011, respectively, and $3,362 and $3,678 for the
twelve month periods ended December 31, 2012 and 2011, respectively.
|
|
|
|
|
|
|
(i)
|
A reconciliation of U.S. GAAP compensation and benefits expense to
compensation and benefits expense, as adjusted:
|
|
|
|
|
Year Ended December 31,
|
|
|
|
($ in thousands)
|
2006
|
|
2007
|
|
2008
|
|
2009
|
|
2010
|
|
2011
|
|
2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Compensation & benefits expense - U.S. GAAP Basis
|
$891,421
|
|
$1,123,068
|
|
$1,128,253
|
|
$1,309,240
|
|
$1,194,168
|
|
$1,168,945
|
|
$1,351,129
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Charges pertaining to cost savings initiatives (Q4)
|
-
|
|
-
|
|
-
|
|
-
|
|
-
|
|
-
|
|
(99,987)
|
|
|
|
Charges pertaining to staff reductions (Q1)
|
-
|
|
-
|
|
-
|
|
-
|
|
-
|
|
-
|
|
(21,754)
|
|
|
|
(Charges) credits pertaining to LFI and other similar arrangements
comp. liability
|
-
|
|
-
|
|
-
|
|
-
|
|
-
|
|
3,024
|
|
(7,557)
|
|
|
|
Acceleration of restricted stock unit vesting related to retirement
policy change
|
-
|
|
-
|
|
-
|
|
-
|
|
(24,860)
|
|
-
|
|
-
|
|
|
|
Acceleration of unamortized restricted stock units
|
-
|
|
-
|
|
-
|
|
(86,514)
|
|
-
|
|
-
|
|
-
|
|
|
|
Acceleration of unamortized deferred cash awards
|
-
|
|
-
|
|
-
|
|
(60,512)
|
|
-
|
|
-
|
|
-
|
|
|
|
LAM Equity Charge
|
-
|
|
-
|
|
(197,550)
|
|
-
|
|
-
|
|
-
|
|
-
|
|
|
|
Compensation related to noncontrolling interests (n)
|
-
|
|
-
|
|
-
|
|
(1,657)
|
|
(3,098)
|
|
(3,740)
|
|
(4,040)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Compensation & benefits expense, as adjusted
|
$891,421
|
|
$1,123,068
|
|
$930,703
|
|
$1,160,557
|
|
$1,166,210
|
|
$1,168,229
|
|
$1,217,791
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LAZARD LTD
|
|
|
Notes to Financial Schedules (continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(j)
|
Special deferred incentive awards are granted outside the year end
compensation process and include grants to new hires.
|
|
|
|
|
|
|
(k)
|
Represents an adjustment to year end foreign exchange spot rate from
full year average rate for year end incentive compensation awards.
|
|
|
|
|
|
|
(l)
|
Under U.S. GAAP, an estimate is made for future forfeitures of the
deferred portion of such awards. This estimate is based on both
historical experience and future expectations. The result reflects
the cost associated with awards that are expected to vest. This
calculation is undertaken in order to present awarded compensation
on a similar basis to GAAP compensation. Amounts for 2007-2009
represent actual forfeiture experience. The 2010-2012 amounts
represent estimated forfeitures.
|
|
|
|
|
|
|
(m)
|
Deferred compensation awards ratio is year end incentive awards
excluding special incentive awards that are outside of the year-end
compensation process such as sign-on and retention awards, divided
by total awarded compensation.
|
|
|
|
|
|
|
(n)
|
Noncontrolling interests include revenue and expenses principally
related to Edgewater, and is a non-GAAP measure. (See Reconciliation
of U.S. GAAP to Selected Summary Financial Information)
|
|
|
|
|
|
|
(o)
|
Represents a reversal of noncontrolling interests related to LAZ-MD
Holdings’ ownership of Lazard Group common membership interests and
an adjustment for Lazard Ltd entity-level taxes to affect a full
exchange of interests and excluding the adjustments noted in (g)
above.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NM
|
Not meaningful
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TBD
|
To be determined
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|